John Dimos, CEO, Fountain Therapeutics describes their approach to the treatment of age-associated diseases and points out that there is a big difference between chronological and biological age. In the search for finding a way to intervene in the aging process, Fountain is taking a hypothesis-free approach and with the aid of artificial intelligence, they are looking at cells holistically to find potential therapeutics that make old cells look and act more like young cells.
@FountainTX #aging #ArtificialIntelligence #AI #DrugDiscovery #AgingTherapeutics #DiseasesofAging
FountainTX.com
Download the transcript here
Empowered Patient Podcast